NasdaqCM - Nasdaq Real Time Price USD

ZyVersa Therapeutics, Inc. (ZVSA)

Compare
2.2000 -0.0900 (-3.93%)
At close: October 22 at 4:00 PM EDT
2.1500 -0.05 (-2.27%)
After hours: October 22 at 7:58 PM EDT
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
22,114.2840
118,506.2710
1,126.1740
685.5670
Total Liabilities Net Minority Interest
11,039.6860
18,511.9430
13,626.3090
9,243.2770
Total Equity Gross Minority Interest
11,074.5980
99,994.3280
-12,500.1350
-8,557.7100
Total Capitalization
11,074.5980
99,994.3280
-12,500.1350
-6,870.6480
Preferred Stock Equity
0.0010
0.0020
--
--
Common Stock Equity
11,074.5970
99,994.3260
-12,500.1350
-8,557.7100
Capital Lease Obligations
8.6560
108.7560
--
--
Net Tangible Assets
-7,573.3050
-11,987.0340
-12,500.1350
-8,557.7100
Working Capital
-6,841.6390
-1,825.4140
-12,814.5270
-7,217.1050
Invested Capital
11,074.5970
99,994.3260
-3,348.6270
-4,740.5540
Tangible Book Value
-7,573.3060
-11,987.0360
-12,500.1350
-8,557.7100
Total Debt
8.6560
108.7560
9,151.5080
3,817.1560
Net Debt
--
--
8,822.9270
3,642.4860
Share Issued
405.2110
25.9480
25.9480
25.9480
Ordinary Shares Number
405.2050
25.9480
25.9480
25.9480
Treasury Shares Number
0.0060
--
--
--
12/31/2020 - 2/11/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers